Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy

The Role of CXCR4 Inhibitors as Novel Antiangiogenesis Agents in Cancer Therapy. ASH. 2004.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.